News Focus
News Focus
Followers 43
Posts 5340
Boards Moderated 0
Alias Born 12/05/2021

Re: churchill_21 post# 556716

Thursday, 01/05/2023 10:31:31 AM

Thursday, January 05, 2023 10:31:31 AM

Post# of 822795

Regardless of whether or not you like NVCR's product, their timeline and path outlined in today's PR is standard practice.

agreed

NWBO's timeline is out of the ordinary.

agreed

I understand and appreciate they wanted a reputable journal first and as a smaller biotech, they will understandably need more time,


I dont understand it, not anymore. What have they achieved? They said it was to thwart the bears. It hasnt. They said it was to support the short attacks. It hasnt. They should have announced topline 6 months after datalock and then after that started working full-time getting the MAA approval with ANOTHER CDMO with Cognate. Then after the request for approval was submitted come with JA and work towards MIA for Toucan subsidiary Advent. We would be now sitting at 4-5$ if not more SP.

but this is getting out of hand.

agreed

NWBO still have a ways to go until they submit an app, my guess is approvals in mid to late 2024. I hope I'm wrong.

I hope that too
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News